[go: up one dir, main page]
More Web Proxy on the site http://driver.im/
You seem to have javascript disabled. Please note that many of the page functionalities won't work as expected without javascript enabled.
 
 

Topic Editors

Brain-Biotech AG, 34-36 Darmstädter Strasse, 64673 Zwingenberg, Germany
Research Centre-Vila Real (CQ-VR), University of Trás-os-Montes and Alto Douro, 5000-801 Vila Real, Portugal

Fermented Food: Health and Benefit

Abstract submission deadline
31 October 2025
Manuscript submission deadline
31 December 2025
Viewed by
15751

Topic Information

Dear Colleagues,

Fermented foods represent a reservoir of bioactive compounds formed through the enzymatic conversion of organic substrates by microorganisms. These foods, spanning cultures globally, undergo controlled microbial growth and biochemical reactions, culminating in products rich in probiotics, organic acids, and bioactive peptides. Research underscores the pivotal role of fermented foods in modulating the gut microbiota, fostering a symbiotic relationship between ingested microorganisms and the host's gastrointestinal environment. The resultant microbial diversity and abundance contribute significantly to gastrointestinal health, influencing digestive processes and fortifying the immune system. Furthermore, fermentation confers enhanced bioavailability of essential nutrients, augmenting the nutritional profile of these foods. Such bioconversion processes render fermented foods potent sources of readily absorbable vitamins, minerals, and antioxidants. Scientific inquiry has elucidated the manifold health benefits associated with regular consumption of fermented foods. These include the amelioration of digestive disorders, mitigation of systemic inflammation, and potential attenuation of chronic disease risk factors. In sum, the scientific discourse surrounding fermented foods underscores their multifaceted contributions to human health, underscoring their role as functional foods capable of synergistically supporting physiological well-being. Embracing these dietary staples resonates with evidence-based nutritional strategies aimed at fostering holistic health and disease prevention. This Topic will host diverse contributions ranging from research papers to up-to-date reviews dealing with fermented food. It includes but is not limited to the following relevant themes:

  • Health Benefits of Fermented Foods;
  • Nutritional Content of Fermented Foods;
  • Microbial Communities within Fermented Food;
  • Fermentation Techniques and Processes;
  • Probiotics and Fermented Foods;
  • Fermented Foods and Digestive Health and Immune Function;
  • Fermented Foods in Traditional Diets;
  • Safety and Quality of Fermented Foods;
  • Yeast and its Role within Fermented Food;
  • Genetic Modification and its Role within Fermentation Processes.

Dr. Niel Van Wyk
Dr. Alice Vilela
Topic Editors

Keywords

  • fermented foods
  • probiotics
  • health and immune function
  • fermentation techniques

Participating Journals

Journal Name Impact Factor CiteScore Launched Year First Decision (median) APC
Applied Microbiology
applmicrobiol
- - 2021 14.3 Days CHF 1000 Submit
Fermentation
fermentation
3.3 3.8 2015 15.4 Days CHF 2100 Submit
Foods
foods
4.7 7.4 2012 14.5 Days CHF 2900 Submit
Microbiology Research
microbiolres
2.1 1.9 2010 15.4 Days CHF 1600 Submit
Microorganisms
microorganisms
4.1 7.4 2013 11.7 Days CHF 2700 Submit

Preprints.org is a multidiscipline platform providing preprint service that is dedicated to sharing your research from the start and empowering your research journey.

MDPI Topics is cooperating with Preprints.org and has built a direct connection between MDPI journals and Preprints.org. Authors are encouraged to enjoy the benefits by posting a preprint at Preprints.org prior to publication:

  1. Immediately share your ideas ahead of publication and establish your research priority;
  2. Protect your idea from being stolen with this time-stamped preprint article;
  3. Enhance the exposure and impact of your research;
  4. Receive feedback from your peers in advance;
  5. Have it indexed in Web of Science (Preprint Citation Index), Google Scholar, Crossref, SHARE, PrePubMed, Scilit and Europe PMC.

Published Papers (10 papers)

Order results
Result details
Journals
Select all
Export citation of selected articles as:
14 pages, 2121 KiB  
Article
Turmeric-Enriched Yogurt: Increased Antioxidant and Phenolic Contents
by Hatice Sıçramaz
Fermentation 2025, 11(3), 127; https://doi.org/10.3390/fermentation11030127 - 5 Mar 2025
Abstract
This study investigated the potential of turmeric powder as a functional additive to yogurt, specifically focusing on its effect on the antioxidant capacity and phenolic content. Yogurt samples were prepared with 0.5% and 1.0% turmeric powder, leading to increases in pH, antioxidant capacity [...] Read more.
This study investigated the potential of turmeric powder as a functional additive to yogurt, specifically focusing on its effect on the antioxidant capacity and phenolic content. Yogurt samples were prepared with 0.5% and 1.0% turmeric powder, leading to increases in pH, antioxidant capacity (from 10% to 51%), and phenolic content (from 1.39 mg to 30.20 mg per 100 g) compared to plain yogurt. While turmeric showed no antibacterial effects in vitro, its addition resulted in a reduction in yogurt bacteria counts, which remained within the regulatory limits. However, exposure to gastric pH and bile salt conditions led to reductions in the antioxidant activity and total phenolic content of turmeric-enriched yogurt, indicating potential limitations in its stability during digestion. Sensory evaluations revealed a preference for plain yogurt; however, turmeric-enriched yogurts also achieved favorable acceptance scores. These findings indicate that turmeric incorporation can enhance the health benefits of yogurt, offering a promising option for consumers desiring functional dairy products. Full article
(This article belongs to the Topic Fermented Food: Health and Benefit)
Show Figures

Figure 1

Figure 1
<p>The antioxidant activity of yogurts. C: control (plain yogurt); TP_05: yogurt with 0.5% turmeric; TP_1: yogurt with 1% turmeric. Yogurts with 0.5% and 1.0% turmeric powder, respectively. The lowercase letters indicate differences between sample groups (<span class="html-italic">p</span> &lt; 0.05).</p>
Full article ">Figure 2
<p>The total phenolic content of the yogurts. C: control (plain yogurt); TP_05: yogurt with 0.5% turmeric; TP_1: yogurt with 1% turmeric. The lowercase letters indicate differences between sample groups (<span class="html-italic">p</span> &lt; 0.05).</p>
Full article ">Figure 3
<p>A biplot of the first two principal components of some of the physicochemical and bioactive properties of the yogurt samples. C: control (plain yogurt); TP_05: yogurt with 0.5% turmeric; TP_1: yogurt with 1% turmeric; AA: antioxidant activity; TPC: total phenolic content; TA: titratable acidity.</p>
Full article ">Figure 4
<p>Antibacterial activity of yogurts evaluated on TSB agar inoculated with <span class="html-italic">S.</span> Typhimurium (<b>a</b>), <span class="html-italic">E. coli</span> (<b>b</b>), and <span class="html-italic">S. aureus</span> (<b>c</b>). C: control (plain yogurt), TP_05: yogurt with 0.5% turmeric, and TP_1: yogurt with 1% turmeric.</p>
Full article ">Figure 5
<p>The total count of yogurt bacteria. C: control (plain yogurt), TP_05: yogurt with 0.5% turmeric, and TP_1: yogurt with 1% turmeric. d1 and d15 represent storage day 1 and day 15, respectively. The lowercase letters indicate differences between sample groups (<span class="html-italic">p</span> &lt; 0.05).</p>
Full article ">Figure 6
<p>The sensory attributes of yogurts. C: control (plain yogurt), TP_05: yogurt with 0.5% turmeric, and TP_1: yogurt with 1% turmeric.</p>
Full article ">
16 pages, 5160 KiB  
Article
Comparison of the Transformation Ability of the Major Saponins in Panax notoginseng by Penicillum fimorum Enzyme and Commercial β-glucosidase
by Feixing Li, Ruixue Zhang, Dongmei Lin, Jin Yang, Ye Yang, Xiuming Cui and Xiaoyan Yang
Microorganisms 2025, 13(3), 495; https://doi.org/10.3390/microorganisms13030495 - 23 Feb 2025
Viewed by 257
Abstract
Ginsenosides with less sugar groups, which are called minor ginsenosides, might have a greater pharmacological activity and better adsorptive ability, but their content in nature is extremely low. In this study, a strain of Penicillium fimorum with a strong saponin transformation ability was [...] Read more.
Ginsenosides with less sugar groups, which are called minor ginsenosides, might have a greater pharmacological activity and better adsorptive ability, but their content in nature is extremely low. In this study, a strain of Penicillium fimorum with a strong saponin transformation ability was isolated from fresh Gastrodia elata. A comparative biotransformation experiment of the major saponins from Panax notoginseng root were conducted using crude enzymes from P. fimorum and commercial β-glucosidase to produce minor ginsenosides. Specifically, the crude enzyme from P. fimorum was able to transform the major saponins from P. notoginseng root into 13 minor saponins in 72 h, while commercial β-glucosidase was able to transform the same major saponins into 15 minor saponins in 72 h. The most significant difference between these two enzymes is their ability to transform Rb1. To the best of our knowledge, the biotransformation ability of crude enzymes from P. fimorum is reported here for the first time. These two enzymes have the potential to improve the economic value of P. notoginseng root and expand the methods for preparing minor saponins by transforming major saponins in the total saponins of P. notoginseng root. Full article
(This article belongs to the Topic Fermented Food: Health and Benefit)
Show Figures

Figure 1

Figure 1
<p>Morphology identification of strain S62. (<b>A</b>) Front view of the morphology of strain S62. (<b>B</b>) Back view of the morphology of strain S62. (<b>C</b>) Microscopic view of mycelium spore morphology of strain S62.</p>
Full article ">Figure 2
<p>TLC analysis of the transformation products of total saponins from <span class="html-italic">P. notoginseng</span> root by <span class="html-italic">P. fimorum</span> for 18 days. S: Standards; 1: Substrate; 2: Transformation products after 18 days of biotransformation. Black square: Transformation products.</p>
Full article ">Figure 3
<p>The neighbor-joining tree based on the ITS rDNA gene sequences of strain S62.</p>
Full article ">Figure 4
<p>The optimum reaction temperature and pH for saponins transformed by the crude enzyme from <span class="html-italic">P. fimorum</span>. (<b>A</b>) pH effect on the transformation of Rb<sub>1</sub>. (<b>B</b>) Temperature effect on the transformation of Rb<sub>1</sub>.</p>
Full article ">Figure 5
<p>The optimum reaction temperature and pH for saponins transformed by <span class="html-italic">β</span>-glucosidase. (<b>A</b>) pH effect on the transformation of Rb<sub>1</sub>. (<b>B</b>) Temperature effect on the transformation of Rb<sub>1</sub>.</p>
Full article ">Figure 6
<p>TLC analysis of the transformation products of different types of saponins (Rb<sub>1</sub>, R<sub>1</sub>, and Rg<sub>1</sub>) by crude enzymes from <span class="html-italic">P. fimorum</span> and <span class="html-italic">β</span>-glucosidase, respectively. (<b>A</b>) TLC analysis of the transformation products by the crude enzyme from <span class="html-italic">P. fimorum</span>. (<b>B</b>) TLC analysis of the transformation products by <span class="html-italic">β</span>-glucosidase. 1, 2, 3: The transformation products of Rb<sub>1</sub>, R<sub>1</sub>, and Rg<sub>1</sub> by the crude enzyme from <span class="html-italic">P. fimorum</span>, respectively. 4, 5, 6: The transformation products of Rb<sub>1</sub>, R<sub>1</sub>, and Rg<sub>1</sub> by <span class="html-italic">β</span>-glucosidase, respectively.</p>
Full article ">Figure 7
<p>HPLC analysis of the transformation products of different types of saponins for 72 h by the crude enzyme from <span class="html-italic">P. fimorum</span>. (<b>A</b>) The transformation products of Rb<sub>1</sub>. (<b>B</b>) The transformation products of Rg<sub>1</sub>. (<b>C</b>) The transformation products of R<sub>1</sub>. (<b>D</b>) The transformation products of Re.</p>
Full article ">Figure 8
<p>HPLC analysis of the transformation products of different types of saponins for 72 h by <span class="html-italic">β</span>-glucosidase. (<b>A</b>) The transformation products of Rb<sub>1</sub>. (<b>B</b>) The transformation products of Rg<sub>1</sub>. (<b>C</b>) The transformation products of R<sub>1</sub>. (<b>D</b>) The transformation products of Re.</p>
Full article ">Figure 9
<p>TLC analysis of the time-course variation in different types of saponins and their transformation products during the biotransformation process by the crude enzyme from <span class="html-italic">P. fimorum</span>. (<b>A</b>) Transformation products analysis of Rb<sub>1</sub> dynamic monitoring. (<b>B</b>) Transformation products analysis of Rg<sub>1</sub> dynamic monitoring. (<b>C</b>) Transformation products analysis of R<sub>1</sub> dynamic monitoring. (<b>D</b>) Transformation products analysis of Re dynamic monitoring.</p>
Full article ">Figure 10
<p>TLC analysis of the time-course variation in different types of saponins and their transformation products during the biotransformation process by <span class="html-italic">β</span>-glucosidase. (<b>A</b>) Transformation products analysis of Rb<sub>1</sub> dynamic monitoring. (<b>B</b>) Transformation products analysis of Rg<sub>1</sub> dynamic monitoring. (<b>C</b>) Transformation products analysis of R<sub>1</sub> dynamic monitoring. (<b>D</b>) Transformation products analysis of Re dynamic monitoring.</p>
Full article ">Figure 11
<p>Structures and productivity of minor ginsenosides from the biotransformation of ginsenosides Rb<sub>1</sub>, Rg<sub>1</sub>, Re, and notoginseng R<sub>1</sub> by crude enzyme from <span class="html-italic">P. fimorum</span> and <span class="html-italic">β</span>-glucosidase, respectively. Red dotted box: Products and yields of minor ginsenosides from biotransformation by the crude enzyme from <span class="html-italic">P. fimorum</span>. Blue dotted box: Products and yields of minor ginsenosides from biotransformation by <span class="html-italic">β</span>-glucosidase.</p>
Full article ">Figure 12
<p>Dynamic changes in the substrate conversion of ginsenosides Rb<sub>1</sub>, Rg<sub>1</sub>, Re, and notoginsenoside R<sub>1</sub> at different reaction times by the crude enzyme from <span class="html-italic">P. fimorum</span> (<b>A</b>) and <span class="html-italic">β</span>-glucosidase (<b>B</b>), respectively.</p>
Full article ">Figure 13
<p>Dynamic changes in the yield of the transformation products of ginsenosides Rb<sub>1</sub> (<b>A</b>), Rg<sub>1</sub> (<b>B</b>), Re (<b>D</b>), and notoginsenoside R<sub>1</sub> (<b>C</b>) at different reaction times by the crude enzyme from <span class="html-italic">P. fimorum</span>.</p>
Full article ">Figure 14
<p>Dynamic changes in the yield of the transformation products of ginsenosides Rb<sub>1</sub> (<b>A</b>), Rg<sub>1</sub> (<b>B</b>), Re (<b>D</b>), and notoginsenoside R<sub>1</sub> (<b>C</b>) at different reactions time by <span class="html-italic">β</span>-glucosidase.</p>
Full article ">
23 pages, 876 KiB  
Review
Exploring the Potential and Challenges of Fermentation in Creating Foods: A Spotlight on Microalgae
by Monize Bürck, Ailton Cesar Lemes, Mariana Buranelo Egea and Anna Rafaela Cavalcante Braga
Fermentation 2024, 10(12), 649; https://doi.org/10.3390/fermentation10120649 - 16 Dec 2024
Viewed by 1368
Abstract
Fermentation is an ancient bioprocess that harnesses the power of microorganisms to convert raw ingredients into valuable and safe food products. There has been a growing interest in using fermentation to create safe, nutritious, and sustainable foods, particularly with the incorporation of microalgae. [...] Read more.
Fermentation is an ancient bioprocess that harnesses the power of microorganisms to convert raw ingredients into valuable and safe food products. There has been a growing interest in using fermentation to create safe, nutritious, and sustainable foods, particularly with the incorporation of microalgae. This review highlights fermentation’s potential benefits and challenges, focusing on microalgae and its metabolites. Bioactive peptides released during microalgae fermentation have garnered attention for their potential health benefits, particularly their antidiabetic actions. Studies suggest that these peptides can help regulate blood glucose levels and improve insulin sensitivity, presenting a promising avenue for developing foods that nourish and contribute to disease prevention. As awareness grows regarding health and sustainability, there is an increasing demand for safe and sustainable food options. Fermented products, particularly those utilizing microalgae, are often perceived positively by among consumers owing to their perceived benefits. Educating consumers on the advantages of fermented foods, including their nutritional value and sustainability, can further enhance market acceptance and commercialization. Thus, the present work aims to explore the literature to study the potential and challenges of fermentation as a tool to produce sustainable foods, focusing on microalgae as an ingredient. Full article
(This article belongs to the Topic Fermented Food: Health and Benefit)
Show Figures

Figure 1

Figure 1
<p>Bibliometric network density map generated in VOSviewer.</p>
Full article ">Figure 2
<p>Generic flowchart for obtaining bioactive peptides from microalgal biomass.</p>
Full article ">
33 pages, 10865 KiB  
Article
A Potential Diabetic-Friendly Food Material: Optimization, Nutritional Quality, Structural Characteristics, and Functional Properties of Oat and Purple Potato Fermented by Ganoderma lucidum Mycelium
by Yingxian Guan, Tong Zhao, Anrong Zhang, Di Zhang, Xiaoxiao Huang, Xiao Fang, Jiajun Geng and Jie Gang
Fermentation 2024, 10(12), 618; https://doi.org/10.3390/fermentation10120618 - 3 Dec 2024
Cited by 1 | Viewed by 795
Abstract
Dietary intervention is the basis for the treatment of diabetes mellitus. This study employed Ganoderma lucidum (GL) mycelium to ferment a compound medium of oat and purple potato (OPP), optimized fermentation conditions to increase the triterpene content in the resulting product (F-OPPF), and [...] Read more.
Dietary intervention is the basis for the treatment of diabetes mellitus. This study employed Ganoderma lucidum (GL) mycelium to ferment a compound medium of oat and purple potato (OPP), optimized fermentation conditions to increase the triterpene content in the resulting product (F-OPPF), and systematically investigated the impact of fermentation on the nutritional quality, structural characteristics, and functional properties of OPP. The results indicated that the triterpene content in F-OPPF significantly increased from 8.53 mg/g to 17.23 mg/g under optimal conditions (temperature: 28 °C, inoculum size: 10%, material quantity: 36 g/250 mL, and fermentation time: day 13). Fermentation resulted in enhanced nutritional quality, with increased contents of protein, soluble protein, crude fiber, ash, mineral elements, essential amino acids, polysaccharides, flavonoids, and total phenols. Mycelium not only enveloped the OPP surface but also penetrated its interior, forming a porous honeycomb-like structure. The types of reactive groups and crystals (C + V-type) were not changed after fermentation, while the crystallinity increased. F-OPPF exhibited positive changes in thermogravimetric properties, antioxidant and hypoglycemic activities, and adsorption capacity of insoluble dietary fiber. Additionally, incorporating F-OPPF into the diet markedly reduced fasting blood glucose levels and promoted weight gain in T2DM rats induced by a high-fat diet and streptozotocin. The fermented groups exhibited improvements in glyco- and lipo-metabolism, oxidative stress, and the function and pathological morphology of the pancreas, liver, and kidneys compared to the unfermented group. Collectively, these findings suggested that GL mycelium fermentation enhanced the nutritional and functional values of OPP, and F-OPPF holds potential as a raw material for developing diabetic-friendly foods. Full article
(This article belongs to the Topic Fermented Food: Health and Benefit)
Show Figures

Figure 1

Figure 1
<p>The overall appearance of OPP and F-OPP on day 11 of fermentation (OPP: compound medium of oat and purple potato; F-OPP: fermented OPP).</p>
Full article ">Figure 2
<p>Effect of temperature (<b>a</b>), material quantity (<b>b</b>), and inoculum size (<b>c</b>) on triterpene content (values with different lowercase letters indicate significant differences at <span class="html-italic">p</span> &lt; 0.05).</p>
Full article ">Figure 3
<p>Three-dimensional response surface diagrams of the effect of interaction between temperature and material quantity (<b>a</b>), temperature and inoculum size (<b>b</b>), material quantity and inoculum size (<b>c</b>) on triterpene content.</p>
Full article ">Figure 4
<p>Changes in triterpene content during fermentation process (values with different lowercase letters indicate significant differences at <span class="html-italic">p</span> &lt; 0.05).</p>
Full article ">Figure 5
<p>Changes in the contents of polysaccharide (<b>a</b>), flavonoid (<b>b</b>), and total phenol (<b>c</b>) during the fermentation process (values with different lowercase letters indicate significant differences at <span class="html-italic">p</span> &lt; 0.05).</p>
Full article ">Figure 6
<p>Scanning electron micrographs of OPPF ((<b>a</b>) ×5k; (<b>c</b>) ×7k) and F-OPPF ((<b>b</b>) ×5k; (<b>d</b>) ×7k) (OPPF: flour of compound medium of oat and purple potato; F-OPPF: fermented product).</p>
Full article ">Figure 7
<p>X-ray diffraction spectra of OPPF, F-OPPF, OPPS, and F-OPPS (OPPF: flour of compound medium of oat and purple potato; F-OPPF: fermented product; OPPS: OPPF starch; and F-OPPS: F-OPPF starch).</p>
Full article ">Figure 8
<p>FTIR spectra of OPPF, F-OPPF, OPPS, and F-OPPS (OPPF: flour of compound medium of oat and purple potato; F-OPPF: fermented product; OPPS: OPPF starch; and F-OPPS: F-OPPF starch).</p>
Full article ">Figure 9
<p>Thermogravimetric curves of OPPF and F-OPPF: (<b>a</b>) thermogravimetric cures; (<b>b</b>) derivative thermogravimetric cures (OPPF: flour of compound medium of oat and purple potato; F-OPPF: fermented product).</p>
Full article ">Figure 10
<p>Changes in antioxidant activities of ethanol extract after fermentation: DPPH (<b>a</b>), hydroxyl (<b>b</b>), and superoxide anion (<b>c</b>) radical scavenging rates with concentration; DPPH (<b>d</b>), hydroxyl (<b>e</b>), and superoxide anion (<b>f</b>) radical scavenging capacities with fermentation time (OPPF: flour of compound medium of oat and purple potato; F-OPPF: fermented product. Values with different uppercase letters at the same extraction concentration indicate significant differences at <span class="html-italic">p</span> &lt; 0.05 between treatments; values with different lowercase letters represent significant differences at <span class="html-italic">p</span> &lt; 0.05 within the same treatment at different extraction concentrations or fermentation time points).</p>
Full article ">Figure 11
<p>Changes in hypoglycemic activities of ethanol extract after fermentation: (<b>a</b>) α-amylase inhibition rate with concentration, (<b>b</b>) α-glucosidase inhibition rate with concentration, (<b>c</b>) α-amylase inhibition capacity with fermentation time, (<b>d</b>) α-glucosidase inhibition capacity with fermentation time (OPPF: flour of compound medium of oat and purple potato; F-OPPF: fermented product. Values with different uppercase letters at the same extraction concentration indicate significant differences at <span class="html-italic">p</span> &lt; 0.05 between treatments; values with different lowercase letters represent significant differences at <span class="html-italic">p</span> &lt; 0.05 within the same treatment at different extraction concentrations or fermentation time points).</p>
Full article ">Figure 12
<p>The adsorption capacities of insoluble dietary fiber in OPPF and F-OPPF: (<b>a</b>) sodium cholate adsorption, (<b>b</b>) cholesterol adsorption, (<b>c</b>) glucose adsorption, and (<b>d</b>) GDRI (GDRI: glucose dialysis retardation index. * <span class="html-italic">p</span> &lt; 0.05 between treatments; ** <span class="html-italic">p</span> &lt; 0.01 between treatments; values with different uppercase letters at the same adsorption/dialysis time point or glucose concentration indicate significant differences at <span class="html-italic">p</span> &lt; 0.05 between treatments; and values with different lowercase letters represent significant differences at <span class="html-italic">p</span> &lt; 0.05 within the same at different adsorption/dialysis time points or glucose concentrations).</p>
Full article ">Figure 13
<p>Effect of F-OPPF on body weight (<b>a</b>), FBG (<b>b</b>), and GSP (<b>c</b>) in T2DM rats (FBG: fasting blood glucose; GSP: glycated serum protein; NC: normal control group; DC: diabetic control group; PC: positive control group; O: OPPF group; FL/FM/FH: low/medium/high-dose F-OPPF group. ## <span class="html-italic">p</span> &lt; 0.01 between the diabetic control group and normal control group; ** <span class="html-italic">p</span> &lt; 0.01 between the intervention groups and diabetic control group; and <sup>∆</sup> <span class="html-italic">p</span> &lt; 0.05, <sup>∆∆</sup> <span class="html-italic">p</span> &lt; 0.01 between the fermented groups and OPPF group).</p>
Full article ">Figure 14
<p>Effect of F-OPPF on OGTT and ITT in T2DM rats: (<b>a</b>) blood glucose levels during the OGTT; (<b>b</b>) the AUC in the OGTT; (<b>c</b>) descension rate of blood glucose during the ITT; (<b>d</b>) the AUC in the ITT (OGTT: oral glucose tolerance test; ITT: insulin tolerance test; AUC: area under the blood glucose curve; NC: normal control group; DC: diabetic control group; PC: positive control group; O: OPPF group; FL/FM/FH: low/medium/high-dose F-OPPF group. ## <span class="html-italic">p</span> &lt; 0.01 between the diabetic control group and normal control group; ** <span class="html-italic">p</span> &lt; 0.01 between the intervention groups and diabetic control group; and <sup>∆∆</sup> <span class="html-italic">p</span> &lt; 0.01 between the fermented groups and OPPF group).</p>
Full article ">Figure 15
<p>Effect of F-OPPF on TC (<b>a</b>), TG (<b>b</b>), HDL-C (<b>c</b>), and LDL-C (<b>d</b>) levels in T2DM rats (TC: total cholesterol; TG: total triglyceride; HDL-C: high-density lipoprotein cholesterol; LDL-C: low-density lipoprotein cholesterol; NC: normal control group; DC: diabetic control group; PC: positive control group; O: OPPF group; FL/FM/FH: low/medium/high-dose F-OPPF group. ## <span class="html-italic">p</span> &lt; 0.01 between the diabetic control group and normal control group; * <span class="html-italic">p</span> &lt; 0.05, ** <span class="html-italic">p</span> &lt; 0.01 between the intervention groups and diabetic control group; and <sup>∆</sup> <span class="html-italic">p</span> &lt; 0.05 between the fermented groups and OPPF group).</p>
Full article ">Figure 16
<p>Effect of F-OPPF on MDA levels (<b>a</b>), T-SOD (<b>b</b>), and GSH-Px (<b>c</b>) activities in T2DM rats (MDA: malondialdehyde; T-SOD: total superoxide dismutase; GSH-Px: glutathione peroxidase; NC: normal control group; DC: diabetic control group; PC: positive control group; O: OPPF group; FL/FM/FH: low/medium/high-dose F-OPPF group. ## <span class="html-italic">p</span> &lt; 0.01 between the diabetic control group and normal control group; * <span class="html-italic">p</span> &lt; 0.05, ** <span class="html-italic">p</span> &lt; 0.01 between the intervention groups and diabetic control group; and <sup>∆</sup> <span class="html-italic">p</span> &lt; 0.05, <sup>∆∆</sup> <span class="html-italic">p</span> &lt; 0.01 between the fermented groups and OPPF group).</p>
Full article ">Figure 17
<p>Effect of F-OPPF on FINS level (<b>a</b>), HOMA-IR index (<b>b</b>), and ISI (<b>c</b>) in T2DM rats (FINS: fasting serum insulin; HOMA-IR: homeostasis model assessment of insulin resistance; ISI: insulin sensitivity index; NC: normal control group; DC: diabetic control group; PC: positive control group; O: OPPF group; FL/FM/FH: low/medium/high-dose F-OPPF group. ## <span class="html-italic">p</span> &lt; 0.01 between the diabetic control group and normal control group; ** <span class="html-italic">p</span> &lt; 0.01 between the intervention groups and diabetic control group; and <sup>∆</sup> <span class="html-italic">p</span> &lt; 0.05 between the fermented groups and OPPF group).</p>
Full article ">Figure 18
<p>Effect of F-OPPF on the pathological morphology of pancreas in T2DM rats: (<b>a</b>) NC, (<b>b</b>) DC, (<b>c</b>) PC, (<b>d</b>) O, (<b>e</b>) FL, (<b>f</b>) FM, and (<b>g</b>) FH (NC: normal control group; DC: diabetic control group; PC: positive control group; O: OPPF group; and FL/FM/FH: low/medium/high-dose F-OPPF group).</p>
Full article ">Figure 19
<p>Effect of F-OPPF on AST (<b>a</b>), ALT (<b>b</b>) activities, and liver glycogen content (<b>c</b>) in T2DM rats (AST: aspartate transaminase; ALT: alanine transaminase; NC: normal control group; DC: diabetic control group; PC: positive control group; O: OPPF group; FL/FM/FH: low/medium/high-dose F-OPPF group. ## <span class="html-italic">p</span> &lt; 0.01 between the diabetic control group and normal control group; * <span class="html-italic">p</span> &lt; 0.05, ** <span class="html-italic">p</span> &lt; 0.01 between the intervention groups and diabetic control group; and <sup>∆</sup> <span class="html-italic">p</span> &lt; 0.05, <sup>∆∆</sup> <span class="html-italic">p</span> &lt; 0.01 between the fermented groups and OPPF group).</p>
Full article ">Figure 20
<p>Effect of F-OPPF on the pathological morphology of liver in T2DM rats: (<b>a</b>) NC, (<b>b</b>) DC, (<b>c</b>) PC, (<b>d</b>) O, (<b>e</b>) FL, (<b>f</b>) FM, and (<b>g</b>) FH (NC: normal control group; DC: diabetic control group; PC: positive control group; O: OPPF group; and FL/FM/FH: low/medium/high-dose F-OPPF group).</p>
Full article ">Figure 21
<p>Effect of F-OPPF on BUN (<b>a</b>) and Scr (<b>b</b>) levels in T2DM rats (BUN: blood urea nitrogen; Scr: serum creatinine; NC: normal control group; DC: diabetic control group; PC: positive control group; O: OPPF group; FL/FM/FH: low/medium/high-dose F-OPPF group. ## <span class="html-italic">p</span> &lt; 0.01 between the diabetic control group and normal control group; ** <span class="html-italic">p</span> &lt; 0.01 between the intervention groups and diabetic control group; and <sup>∆∆</sup> <span class="html-italic">p</span> &lt; 0.01 between the fermented groups and OPPF group).</p>
Full article ">Figure 22
<p>Effect of F-OPPF on the pathological morphology of kidneys in T2DM rats: (<b>a</b>) NC, (<b>b</b>) DC, (<b>c</b>) PC, (<b>d</b>) O, (<b>e</b>) FL, (<b>f</b>) FM, and (<b>g</b>) FH (NC: normal control group; DC: diabetic control group; PC: positive control group; O: OPPF group; and FL/FM/FH: low/medium/high-dose F-OPPF group).</p>
Full article ">
16 pages, 4159 KiB  
Article
Optimizing the Brewing Process, Metabolomics Analysis, and Antioxidant Activity Analysis of Complexed Hongqu Rice Wine with Kiwiberry
by Mengze Wang, Yuxin Liu, Xing Guo, Yuping Ding and Dejiang Liu
Fermentation 2024, 10(10), 494; https://doi.org/10.3390/fermentation10100494 - 26 Sep 2024
Viewed by 1071
Abstract
Hongqu rice wine is a traditional Chinese yellow wine produced from a single ingredient. To enhance the competitiveness of the product and better adapt to market development trends, the development of a complexed Hongqu rice wine using a variety of ingredients is necessary [...] Read more.
Hongqu rice wine is a traditional Chinese yellow wine produced from a single ingredient. To enhance the competitiveness of the product and better adapt to market development trends, the development of a complexed Hongqu rice wine using a variety of ingredients is necessary to enhance the nutritional value of the product and diversify its flavor. This study explored production technology for the development of a complexed Hongqu rice wine using kiwiberry as the raw material. The mixed fermentation process was optimized using single-factor experiments and response surface methodology (RSM). The optimal conditions were a juice addition time of 93 h, a fermentation temperature of 31 °C, and a juice addition amount of 75 g/100 g. Under these conditions, the complexed Hongqu rice wine had an alcohol content of 8.7% vol, a total phenolic content of 0.42 mg GAE/mL, and a total flavonoid content of 0.32 mg CE/mL. In total, 27 metabolites were identified. The relative levels of 15 metabolites, including quercetin-3-glucoside and rutin, increased significantly after the adding of the kiwiberry (VIP > 1.0, p < 0.05, FC > 2). Antioxidant activity experiments showed that the Hongqu rice wine had notable antioxidant capacity and that adding the kiwiberry significantly enhanced this capacity. Additionally, the complexed Hongqu rice wine exhibited hypoglycemic and bile acid-binding properties. It achieved 78.68 ± 0.44% inhibition of α-amylase and 58.02 ± 0.50% inhibition of α-glucosidase. The binding activities with sodium glycocholate, sodium cholate, and sodium taurocholate were 40.25 ± 0.64%, 49.08 ± 1.05%, and 60.58 ± 0.80%, respectively. Consequently, a complexed Hongqu rice wine rich in quercetin-3-glucoside and rutin, with notable antioxidant activities, was developed. This wine has potential applications in functional food development. Full article
(This article belongs to the Topic Fermented Food: Health and Benefit)
Show Figures

Figure 1

Figure 1
<p>Single-factor experiment results. Values with different letters indicate significant differences (<span class="html-italic">p</span> &lt; 0.05). (<b>A</b>) effect of juice addition time on alcohol content, (<b>B</b>) effect of fermentation temperature on alcohol content, (<b>C</b>) effect of juice addition amount on alcohol content, (<b>D</b>) effect of juice addition time on sensory score, (<b>E</b>) effect of fermentation temperature on sensory score, and (<b>F</b>) effect of juice addition amount on sensory scores.</p>
Full article ">Figure 2
<p>Response surface and contour plots of alcohol content: (<b>A</b>,<b>D</b>) effects of juice addition time and fermentation temperature, (<b>B</b>,<b>E</b>) effects of juice addition time and juice addition amount, and (<b>C</b>,<b>F</b>) effects of fermentation temperature and juice addition amount.</p>
Full article ">Figure 3
<p>Response surface and contour plots for sensory score: (<b>A</b>,<b>D</b>) effects of juice addition time and fermentation temperature, (<b>B</b>,<b>E</b>) effects of juice addition time and juice addition amount, and (<b>C</b>,<b>F</b>) effects of fermentation temperature and juice addition amount.</p>
Full article ">Figure 4
<p>Functional component contents in <span class="html-italic">Hongqu</span> rice wine and complexed <span class="html-italic">Hongqu</span> rice wine: (<b>A</b>) polyphenol content and (<b>B</b>) flavonoid content. “***” represents “<span class="html-italic">p</span> &lt; 0.001”.“****” represents “<span class="html-italic">p</span> &lt; 0.0001”.</p>
Full article ">Figure 5
<p>Metabolomic analysis of <span class="html-italic">Hongqu</span> rice wine and complexed <span class="html-italic">Hongqu</span> rice wine: (<b>A</b>) PCA score plot, (<b>B</b>) OPLS-DA score plot, (<b>C</b>) VIP plot, and (<b>D</b>) clustering heatmap.</p>
Full article ">Figure 6
<p>Antioxidant capacities of <span class="html-italic">Hongqu</span> rice wine and complexed <span class="html-italic">Hongqu</span> rice wine: (<b>A</b>) DPPH radical scavenging capacity, (<b>B</b>) ABTS radical scavenging capacity, (<b>C</b>) OH radical scavenging capacity, and (<b>D</b>) Fe<sup>3</sup>⁺ reducing power. “***” represents “<span class="html-italic">p</span> &lt; 0.001”.“****” represents “<span class="html-italic">p</span> &lt; 0.0001”.</p>
Full article ">Figure 7
<p>In vitro inhibitory activities of <span class="html-italic">Hongqu</span> rice wine and complexed <span class="html-italic">Hongqu</span> rice wine on key metabolic enzymes for carbohydrates and lipids: (<b>A</b>) α-Amylase inhibitory activity and (<b>B</b>) α-Glucosidase inhibitory activity. “*” represents “<span class="html-italic">p</span> &lt; 0.05”.“****” represents “<span class="html-italic">p</span> &lt; 0.0001”.</p>
Full article ">Figure 8
<p>Bile acid-binding capacities of <span class="html-italic">Hongqu</span> rice wine and complexed <span class="html-italic">Hongqu</span> rice wine: (<b>A</b>) sodium cholate-binding capacity, (<b>B</b>) sodium taurocholate-binding capacity, and (<b>C</b>) sodium glycocholate-binding capacity. “*” represents “<span class="html-italic">p</span> &lt; 0.05”.“****” represents “<span class="html-italic">p</span> &lt; 0.0001”.</p>
Full article ">
18 pages, 3515 KiB  
Article
Identification of Bioactive Substances Derived from the Probiotic-Induced Bioconversion of Lagerstroemia speciosa Pers. Leaf Extract That Have Beneficial Effects on Diabetes and Obesity
by Byung Chull An, Sang Hee Kwak, Jun Young Ahn, Hye Yeon Won, Tae Hoon Kim, Yongku Ryu and Myung Jun Chung
Microorganisms 2024, 12(9), 1848; https://doi.org/10.3390/microorganisms12091848 - 6 Sep 2024
Viewed by 1162
Abstract
Lagerstroemia speciosa L. (Banaba) has been used as a functional food because of its diuretic, decongestant, antipyretic, anti-hyperglycemic, and anti-adipogenic activities. Triterpene acids, including corosolic acid, oleanolic acid, and asiatic acid, are the principal phytochemicals in Banaba and are potentially anti-diabetic substances, owing [...] Read more.
Lagerstroemia speciosa L. (Banaba) has been used as a functional food because of its diuretic, decongestant, antipyretic, anti-hyperglycemic, and anti-adipogenic activities. Triterpene acids, including corosolic acid, oleanolic acid, and asiatic acid, are the principal phytochemicals in Banaba and are potentially anti-diabetic substances, owing to their effect on blood glucose concentration. Bioconversion of Banaba leaf extract (BLE) by Lactobacillus plantarum CBT-LP3 improved the glucose uptake, insulin secretion, and fat browning of this functional food. Furthermore, we identified asiatic acid, which was found to be increased by 3.8-fold during the L. plantarum CBT-LP3-mediated bioconversion process using metabolite profiling. Most previous studies have focused on corosolic acid, another triterpene acid that is a known anti-diabetic compound and is used to standardize BLE preparations. However, asiatic acid is the second most common of the triterpene acids and is also well known to have anti-diabetic properties. The present study has provided strong evidence that asiatic acid represents an alternative to corosolic acid as the most important active compound. These results suggest that the probiotic-mediated bioconversion of BLE may improve the anti-diabetic effects of this functional food. This implies that the consumption of a probiotic should be encouraged for people undergoing BLE treatment to improve its anti-diabetic effects. Full article
(This article belongs to the Topic Fermented Food: Health and Benefit)
Show Figures

Figure 1

Figure 1
<p>Cytotoxicity of each substance. The cytotoxicity of each test substance was assessed prior to further experiments. (<b>A</b>) Two-microliter (2% <span class="html-italic">v</span>/<span class="html-italic">v</span>) aliquots of each substance were added to 3T3-L1 cells for 48 h, and the viability of the cells was then determined using a multiplate reader and a WST-8 Cell Viability Assay Kit. The data are the mean ± SEM of three independent experiments (<span class="html-italic">n</span> = 6). (<b>B</b>) Two-microliter (2% <span class="html-italic">v</span>/<span class="html-italic">v</span>) aliquots of each substance were incubated with INS-1 cells for 48 h, and the cell viability was then determined using a microplate reader and a WST-8 Cell Viability Assay Kit. The data are the mean ± SEM of three independent experiments (<span class="html-italic">n</span> = 5). * <span class="html-italic">p</span> &lt; 0.05 and **** <span class="html-italic">p</span> &lt; 0.0001 vs. control.</p>
Full article ">Figure 2
<p>Effects of each substance on glucose uptake by 3T3-L1 cells. (<b>A</b>) Scheme for the experiment. (<b>B</b>) Glucose uptake, determined at the pre-adipocyte stage, in the absence of methylxanthine, dexamethasone, and insulin (MDI) treatment. The data are the mean ± SEM of three independent experiments (<span class="html-italic">n</span> = 3). * <span class="html-italic">p</span> &lt; 0.05 vs. control. (<b>C</b>) Glucose uptake, determined after adipocyte differentiation resulting from the MDI treatment of 3T3-L1 cells, determined using a Glucose Uptake-Glo<sup>TM</sup> Assay kit. The data are the mean ± SEM for three independent experiments (<span class="html-italic">n</span> = 4). # <span class="html-italic">p</span> &lt; 0.05 vs. preadipocyte, **** <span class="html-italic">p</span> &lt; 0.0001 vs. MDI. (<b>D</b>) Relative mRNA expression of glucose uptake-related genes in 3T3-L1 cells, measured using qPCR, with <span class="html-italic">Actb</span> as the reference gene. The data are the mean ± SEM of three independent experiments (<span class="html-italic">n</span> = 4). #### <span class="html-italic">p</span> &lt; 0.0001 vs. preadipocyte, and ** <span class="html-italic">p</span> &lt; 0.01, *** <span class="html-italic">p</span> &lt; 0.001 and **** <span class="html-italic">p</span> &lt; 0.0001 vs. vehicle.</p>
Full article ">Figure 3
<p>Induction of browning of 3T3-L1 cells by each substance. (<b>A</b>) To determine whether each substance affected the total lipid content of the 3T3-L1 cells, we examined the cells after ORO staining using a bright-field microscope (magnification ×4). The stain was then eluted from the cells using 100% isopropanol and the absorbance of the eluted stain was measured at 490 nm. The data are the mean ± SEM of three independent experiments (<span class="html-italic">n</span> = 5). #### <span class="html-italic">p</span> &lt; 0.0001 vs. preadipocyte and ** <span class="html-italic">p</span> &lt; 0.01 vs. vehicle. (<b>B</b>) To determine whether each substance affected the mRNA expression of lipolysis-related genes, their expression was measured using qPCR and <span class="html-italic">Actb</span> as the reference gene. The data are the mean ± SEM of three independent experiments (<span class="html-italic">n</span> = 4). #### <span class="html-italic">p</span> &lt; 0.0001 vs. preadipocyte, **** <span class="html-italic">p</span> &lt; 0.0001 vs. vehicle. (<b>C</b>) To determine whether each substance stimulated browning in 3T3-L1 cells, the number and size of the cells were counted using a bright-field microscope (magnification ×10). A low value indicated morphologically changed 3T3-L1 cells which are significantly reduced adipocytes in cytosol. (<b>D</b>) To determine whether each substance affected the mRNA expression of the white adipocyte marker gene (WDNM1) and brown adipocyte marker gene (UCP-1), their expression was measured using qPCR with <span class="html-italic">Actb</span> as the reference gene. The data are the mean ± SEM of three independent experiments (Left: <span class="html-italic">n</span> = 3, Right: <span class="html-italic">n</span> = 4). #### <span class="html-italic">p</span> &lt; 0.0001 and ### <span class="html-italic">p</span> &lt; 0.001 vs. preadipocyte, **** <span class="html-italic">p</span> &lt; 0.0001, ** <span class="html-italic">p</span> &lt; 0.01, and * <span class="html-italic">p</span> &lt; 0.05, vs. vehicle.</p>
Full article ">Figure 4
<p>Effect of each substance on insulin secretion. (<b>A</b>) To determine the effects of each substance on insulin secretion by INS-1 cells, the cells were incubated under normal and high-glucose conditions, and the insulin concentration of the medium was measured using a Human Insulin ELISA kit. The data are the mean ± SEM of three independent experiments (Left: <span class="html-italic">n</span> = 3, Right: <span class="html-italic">n</span> = 3). ### <span class="html-italic">p</span> &lt; 0.001 vs. KRBH, **** <span class="html-italic">p</span> &lt; 0.0001, *** <span class="html-italic">p</span> &lt; 0.001, ** <span class="html-italic">p</span> &lt; 0.01 vs. vehicle. (<b>B</b>) To evaluate the recovery of INS-1 cells from STZ-induced damage in the presence of each test substance, a WST-8 Cell Viability Assay Kit was used. The data are the mean ± SEM of three independent experiments (<span class="html-italic">n</span> = 3). * <span class="html-italic">p</span> &lt; 0.01 vs. control. (<b>C</b>) To determine how each substance could affect cell survival following TBHP treatment, which rapidly increases ROS production by cells, the ROS-scavenging properties of each substance in INS-1 cells was investigated using L-ascorbic acid as a positive control. The data are the mean ± SEM of three independent experiments (<span class="html-italic">n</span> = 6). **** <span class="html-italic">p</span> &lt; 0.0001 vs. control.</p>
Full article ">Figure 5
<p>Comparison of the metabolomic profiles of BLE and BBLE. A PLS-DA score plot and Venn diagram derived from the LC-MS data are shown. (<b>A</b>) Partial least-squares discriminant analysis (PLS-DA) was performed to obtain a global overview of the difference in the metabolites present in BLE and BBLE. (<b>B</b>) Venn diagram of the number of annotated metabolites in BLE and BBLE, obtained using negative ion mode. (<b>C</b>) Volcano plot of the metabolites present at differing concentrations in BLE and BBLE. The <span class="html-italic">p</span>-value was calculated using Student’s <span class="html-italic">t</span>-test. Red dots denote significant (<span class="html-italic">p</span> &lt; 0.05) differences with fold changes &gt;2; blue dots represent significant differences (<span class="html-italic">p</span> &lt; 0.05), black dots represent a fold change &gt;2, and clear dots represent no significance (<span class="html-italic">p</span> &gt; 0.05) and a fold change &lt; 2.</p>
Full article ">Figure 6
<p><span class="html-italic">L. plantarum</span> CBT-LP3-mediated conversion of ursolic acid to asiatic acid. (<b>A</b>) To determine whether asiatic acid can stimulate glucose uptake in 3T3-L1 cells, we measured the glucose uptake in the presence of insulin (0.25 nM) and asiatic acid in 3T3-L1 cells at the preadipocyte stage. The data are the mean ± SEM of three independent experiments (<span class="html-italic">n</span> = 4). ** <span class="html-italic">p</span> &lt; 0.01 vs. control. (<b>B</b>) To evaluate the <span class="html-italic">L. plantarum</span> CBT-LP3-mediated bioconversion of ursolic acid to asiatic acid, <span class="html-italic">L. plantarum</span> CBT-LP3 cells (10<sup>4</sup> cfu) were incubated in M9 culture media in the presence of ursolic acid (100 μg/mL) at 37 °C for 72 h. The two polar metabolites, ursolic acid and its product asiatic acid (blue circle), were extracted using a double volume of butanol (<span class="html-italic">v</span>/<span class="html-italic">v</span>), which was then completely evaporated. The mixture was resuspended in methanol and then HPLC analysis was performed.</p>
Full article ">
11 pages, 484 KiB  
Article
Artisanal Cream Cheese Fermented with Kefir Grains
by Denise Rossi Freitas, Eliana Setsuko Kamimura and Mônica Roberta Mazalli
Fermentation 2024, 10(8), 420; https://doi.org/10.3390/fermentation10080420 - 13 Aug 2024
Cited by 1 | Viewed by 1309
Abstract
This is the first study that investigates the effect of kefir with an emphasis on the production of short-chain fatty acids (SCFAs) during the fermentation process in food products. The products developed and characterized were an artisanal cream cheese without cream and one [...] Read more.
This is the first study that investigates the effect of kefir with an emphasis on the production of short-chain fatty acids (SCFAs) during the fermentation process in food products. The products developed and characterized were an artisanal cream cheese without cream and one with added cream, and for the analysis of the fatty acid profile, both cream cheeses were compared with commercial cream cheese. The artisanal cream cheese had a high amount of lactic acid bacteria characterizing the product formed by Lactobacilli and a low concentration of lactose due to the fermentation process. Compared to commercial cream cheese, our products without and with added cream had a higher concentration of short-chain fatty acids (SCFAs), especially butyric acid, which is important for the health of the gastrointestinal tract, omega 3, and oleic fatty acid, which has been associated with the prevention and control of some diseases. Overall, the artisanal cream cheese cream with fermented cream with kefir grains is a functional product with an innovative character compared to current products on the market and was well accepted by the younger public. This new product comes as an option for those who need to change their eating habits and maintain a healthy lifestyle. Full article
(This article belongs to the Topic Fermented Food: Health and Benefit)
Show Figures

Figure 1

Figure 1
<p>Flowchart of artisanal production of fermented kefir grains to obtain cream cheese.</p>
Full article ">
28 pages, 2877 KiB  
Article
Solid-State Fermentation of Quinoa Flour: An In-Depth Analysis of Ingredient Characteristics
by Ophélie Gautheron, Laura Nyhan, Arianna Ressa, Maria Garcia Torreiro, Ali Zein Alabiden Tlais, Claudia Cappello, Marco Gobbetti, Andreas Klaus Hammer, Emanuele Zannini, Elke K. Arendt and Aylin W. Sahin
Fermentation 2024, 10(7), 360; https://doi.org/10.3390/fermentation10070360 - 16 Jul 2024
Cited by 3 | Viewed by 2201
Abstract
Plant protein ingredients are gaining attention for human nutrition, yet they differ significantly from animal proteins in functionality and nutrition. Fungal solid-state fermentation (SSF) can modulate the composition and functionality, increasing their applicability in foods. Quinoa flour (QF) served as a substrate for [...] Read more.
Plant protein ingredients are gaining attention for human nutrition, yet they differ significantly from animal proteins in functionality and nutrition. Fungal solid-state fermentation (SSF) can modulate the composition and functionality, increasing their applicability in foods. Quinoa flour (QF) served as a substrate for Aspergillus oryzae and Rhizopus oligosporus, resulting in two fermented ingredients (QFA and QFR) with different nutritional, functional, and aroma characteristics. A higher increase in protein (+35%) and nitrogen (+24%) was observed in the QFA, while fat was predominantly increased in the QFR (+78%). Fermentable oligo-, di-, monosaccharides and polyols (FODMAPs) decreased in the QFR but increased in the QFA due to polyol production. Metabolomic analysis revealed higher lactic acid concentrations in the QFA, and higher citric, malic, and fumaric acid contents in the QFR. The SSF reduced most antinutrients, while R. oligosporus produced saponins. Olfactometry showed the development of fruity ester compounds and a decrease in metallic and cardboard aromas. Both ingredients showed an enhanced water-holding capacity, with the QFA also demonstrating an increased oil-holding capacity. Complex formation increased the particle size, reduced the solubility, and decreased the foaming properties. Mycelium production darkened the ingredients, with the QFR having a higher differential colour index. This study highlights the potential of SSF to produce ingredients with improved nutritional, sensory, and functional properties. Full article
(This article belongs to the Topic Fermented Food: Health and Benefit)
Show Figures

Figure 1

Figure 1
<p>Light transmission profiles of the QF (<b>A</b>), QFA (<b>B</b>), and QFR (<b>C</b>) emulsions.</p>
Full article ">Figure 2
<p>Protein profiles of the quinoa ingredients with the reference ladder on the first position (L), followed by the QF (A), QFA (B), and QFR (C).</p>
Full article ">Figure 3
<p>Differences in aroma intensity during fermentation compared to the quinoa flour based on GC-FID peak area (ΔQFA = QFA − QF and ΔQFR = QFR − QF) of compounds showing a significant difference (minimum of one for at least one of the fermented ingredients).</p>
Full article ">Figure 4
<p>Changes in organic acid concentrations of the quinoa flour fermented with <span class="html-italic">Aspergillus oryzae</span> (QFA) or <span class="html-italic">Rhizopus oligosporus</span> (QFR) compared to the quinoa flour (QF) (ΔQFA = QFA − QF and ΔQFR= QFR − QF) as detected by MS-Omics and expressed as g/100 g on a dry matter basis.</p>
Full article ">Figure A1
<p>Detailed FODMAP contents of quinoa flour (QF) and quinoa flour fermented with <span class="html-italic">Aspergillus oryzae</span> (QFA) and <span class="html-italic">Rhizopus oligosporus</span> (QFR), expressed as g/100 g ± standard deviation on a dry matter basis. Values within a row, followed by different letters, are significantly different (<span class="html-italic">p</span> &lt; 0.05).</p>
Full article ">Figure A2
<p>Particle size distribution for the QF, QFA, and QFR, expressed as volume density [%] as a function of size [μm].</p>
Full article ">Figure A3
<p>WordClouds for the QF (<b>A</b>), QFA (<b>B</b>), and QFR (<b>C</b>) based on the aroma detected by olfactometry. Larger font sizes indicate the predominance of aromas associated with the compounds.</p>
Full article ">Figure A4
<p>Differences in aroma intensity during fermentation compared to the quinoa flour (ΔQFA = QFA − QF and ΔQFR = QFR − QF) for the unknown compounds having a significant difference (minimum of one for at least one of the fermented ingredients).</p>
Full article ">
20 pages, 1181 KiB  
Review
Bioactive Peptides Derived from Whey Proteins for Health and Functional Beverages
by Margarita Saubenova, Yelena Oleinikova, Alexander Rapoport, Sviatoslav Maksimovich, Zhanerke Yermekbay and Elana Khamedova
Fermentation 2024, 10(7), 359; https://doi.org/10.3390/fermentation10070359 - 16 Jul 2024
Cited by 9 | Viewed by 2786
Abstract
Milk serves as a crucial source of natural bioactive compounds essential for human nutrition and health. The increased production of high-protein dairy products is a source of whey—a valuable secondary product that, along with other biologically valuable substances, contains significant amounts of whey [...] Read more.
Milk serves as a crucial source of natural bioactive compounds essential for human nutrition and health. The increased production of high-protein dairy products is a source of whey—a valuable secondary product that, along with other biologically valuable substances, contains significant amounts of whey proteins and is often irrationally used or not utilized at all. Acid whey, containing almost all whey proteins and approximately one-quarter of casein, presents a valuable raw material for generating peptides with potential health benefits. These peptides exhibit properties such as antioxidant, antimicrobial, anti-inflammatory, anticarcinogenic, antihypertensive, antithrombotic, opioid, mineral-binding, and growth-stimulating activities, contributing to improved human immunity and the treatment of chronic diseases. Bioactive peptides can be produced by enzymatic hydrolysis using a variety of proteolytic enzymes, plant extracts, and microbial fermentation. With the participation of plant enzymes, peptides that inhibit angiotensin-converting enzyme are most often obtained. The use of enzymatic hydrolysis and microbial fermentation by lactic acid bacteria (LAB) produces more diverse peptides from different whey proteins with α-lactalbumin and β-lactoglobulin as the main targets. The resulting peptides of varying lengths often have antimicrobial, antioxidant, antihypertensive, and antidiabetic characteristics. Peptides produced by LAB are promising for use in medicine and the food industry as antioxidants and biopreservatives. Other beneficial properties of LAB-produced, whey-derived peptides have not yet been fully explored and remain to be studied. The development of whey drinks rich in bioactive peptides and based on the LAB proteolytic activity is underway. The strain specificity of LAB proteases opens up broad prospects for combining microorganisms to obtain products with the widest range of beneficial properties. Full article
(This article belongs to the Topic Fermented Food: Health and Benefit)
Show Figures

Figure 1

Figure 1
<p>Whey proteins.</p>
Full article ">Figure 2
<p>Sources and significance of milk and whey peptides.</p>
Full article ">
16 pages, 1159 KiB  
Article
Harnessing Fermented Soymilk Production by a Newly Isolated Pediococcus acidilactici F3 to Enhance Antioxidant Level with High Antimicrobial Activity against Food-Borne Pathogens during Co-Culture
by Sitha Chan, Kaemwich Jantama, Chutinun Prasitpuriprecha, Supasson Wansutha, Chutchawan Phosriran, Laddawan Yuenyaow, Kuan-Chen Cheng and Sirima Suvarnakuta Jantama
Foods 2024, 13(13), 2150; https://doi.org/10.3390/foods13132150 - 7 Jul 2024
Viewed by 1600
Abstract
In this study, a newly isolated Pediococcus acidilactici F3 was used as probiotic starter for producing fermented soymilk to enhance antioxidant properties with high antimicrobial activity against food-borne pathogens. The objectives of this study were to investigate optimized fermentation parameters of soymilk for [...] Read more.
In this study, a newly isolated Pediococcus acidilactici F3 was used as probiotic starter for producing fermented soymilk to enhance antioxidant properties with high antimicrobial activity against food-borne pathogens. The objectives of this study were to investigate optimized fermentation parameters of soymilk for enhancing antioxidant property by P. acidilactici F3 and to assess the dynamic antimicrobial activity of the fermented soymilk during co-culturing against candidate food-borne pathogens. Based on central composite design (CCD) methodology, the maximum predicted percentage of antioxidant activity was 78.9% DPPH inhibition. After model validation by a 2D contour plot, more suitable optimum parameters were adjusted to be 2% (v/v) inoculum and 2.5 g/L glucose incubated at 30 °C for 18 h. These parameters could provide the comparable maximum percentage of antioxidant activity at 74.5 ± 1.2% DPPH inhibition, which was up to a 23% increase compared to that of non-fermented soymilk. During 20 days of storage at 4 °C, antioxidant activities and viable cells of the fermented soymilk were stable while phenolic and organic contents were slightly increased. Interestingly, the fermented soymilk completely inhibited food-borne pathogens, Salmonella Typhimurium ATCC 13311, and Escherichia coli ATCC 25922 during the co-culture incubation. Results showed that the soymilk fermented by P. acidilactici F3 may be one of the alternative functional foods enriched in probiotics, and the antioxidation and antimicrobial activities may retain nutritional values and provide health benefits to consumers with high confidence. Full article
(This article belongs to the Topic Fermented Food: Health and Benefit)
Show Figures

Figure 1

Figure 1
<p>The 2D plots of the optimized parameters for %DPPH inhibition produced by <span class="html-italic">P. acidilactici</span> F3 in fermented soymilk.</p>
Full article ">Figure 2
<p>The percentage of DPPH scavenging activity (<b>A</b>), phenolic content (<b>B</b>), <span class="html-italic">P. acidilactici</span> F3 viable counts and pH (<b>C</b>), and organic acids production (<b>D</b>) of fermented soymilk during 20 days of storage at 4 °C. Each bar bearing different lowercase letters and numbers represents the significant difference (<span class="html-italic">p</span> &lt; 0.05).</p>
Full article ">Figure 3
<p>Antimicrobial activity against (<b>A</b>) <span class="html-italic">E. coli</span> ATCC 25922, (<b>B</b>) <span class="html-italic">S.</span> Typhimurium ATCC 13311, and (<b>C</b>) <span class="html-italic">S. aureus</span> ATCC 25923 co-incubated at 37 <span class="html-small-caps">°</span>C for 24 h with 20-day-refrigerated soymilks fermented by <span class="html-italic">P. acidilactici</span> F3.</p>
Full article ">
Back to TopTop